Correlation Between Nuvectis Pharma and Bio Techne

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and Bio Techne at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and Bio Techne into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvectis Pharma and Bio Techne Corp, you can compare the effects of market volatilities on Nuvectis Pharma and Bio Techne and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of Bio Techne. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and Bio Techne.

Diversification Opportunities for Nuvectis Pharma and Bio Techne

0.07
  Correlation Coefficient

Significant diversification

The 3 months correlation between Nuvectis and Bio is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and Bio Techne Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Techne Corp and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with Bio Techne. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Techne Corp has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and Bio Techne go up and down completely randomly.

Pair Corralation between Nuvectis Pharma and Bio Techne

Given the investment horizon of 90 days Nuvectis Pharma is expected to generate 9.41 times less return on investment than Bio Techne. In addition to that, Nuvectis Pharma is 2.71 times more volatile than Bio Techne Corp. It trades about 0.0 of its total potential returns per unit of risk. Bio Techne Corp is currently generating about 0.03 per unit of volatility. If you would invest  6,776  in Bio Techne Corp on September 2, 2024 and sell it today you would earn a total of  760.00  from holding Bio Techne Corp or generate 11.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Nuvectis Pharma  vs.  Bio Techne Corp

 Performance 
       Timeline  
Nuvectis Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nuvectis Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Nuvectis Pharma is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Bio Techne Corp 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Bio Techne Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating fundamental indicators, Bio Techne may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Nuvectis Pharma and Bio Techne Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nuvectis Pharma and Bio Techne

The main advantage of trading using opposite Nuvectis Pharma and Bio Techne positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, Bio Techne can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Techne will offset losses from the drop in Bio Techne's long position.
The idea behind Nuvectis Pharma and Bio Techne Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Fundamental Analysis
View fundamental data based on most recent published financial statements
Global Correlations
Find global opportunities by holding instruments from different markets
Transaction History
View history of all your transactions and understand their impact on performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like